Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Famciclovir 1000 mg	312
Overall Study	STARTED	Placebo Comparator	151
Overall Study	Randomized and Took Study Drug	Famciclovir 1000 mg	206
Overall Study	Randomized and Took Study Drug	Placebo Comparator	98
Overall Study	Intent to Treat Population	Famciclovir 1000 mg	201
Overall Study	Intent to Treat Population	Placebo Comparator	98
Overall Study	Participants Completing First Recurrence	Famciclovir 1000 mg	187
Overall Study	Participants Completing First Recurrence	Placebo Comparator	92
Overall Study	Modified Intent to Treat Population	Famciclovir 1000 mg	152
Overall Study	Modified Intent to Treat Population	Placebo Comparator	78
Overall Study	COMPLETED	Famciclovir 1000 mg	142
Overall Study	COMPLETED	Placebo Comparator	75
Overall Study	NOT COMPLETED	Famciclovir 1000 mg	170
Overall Study	NOT COMPLETED	Placebo Comparator	76

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00477334/flow